BeOne Medicines (ONC) Short-term Investments (2015 - 2023)

BeOne Medicines (ONC) has 9 years of Short-term Investments data on file, last reported at $2.6 million in Q4 2023.

• On a quarterly basis, Short-term Investments fell 99.61% year-over-year to $2.6 million in Q4 2023; TTM through Dec 2023 was $2.6 million, a 99.61% decrease from a year earlier, with the FY2023 full-year figure at $2.6 million, down 99.61% from the prior year.
• Short-term Investments for Q4 2023 stood at $2.6 million, down from $107.0 million in the prior quarter.
• Over the last five years, Short-term Investments for ONC reached as high as $3.3 billion in Q4 2020 and fell as low as $2.6 million in Q4 2023.
• Historically, Short-term Investments has averaged $1.4 billion across 5 years, with a median of $1.0 billion in 2022.
• Across the five-year window, Short-term Investments jumped 796.21% in 2020 and sank 99.61% in 2023, its largest moves.
• Year by year, Short-term Investments stood at $364.7 million in 2019, then soared by 796.21% to $3.3 billion in 2020, then sank by 31.41% to $2.2 billion in 2021, then tumbled by 70.33% to $665.3 million in 2022, then sank by 99.61% to $2.6 million in 2023.
• Per Business Quant data, the three most recent Short-term Investments figures were $2.6 million in Q4 2023, $107.0 million in Q3 2023, and $105.7 million in Q2 2023.